相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activation of Sphingosine-1-Phosphate Receptor 1 in the Spinal Cord Produces Mechanohypersensitivity Through the Activation of Inflammasome and IL-1β Pathway
Timothy M. Doyle et al.
JOURNAL OF PAIN (2019)
Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain
Katherine Stockstill et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Differential Tolerance to FTY720-Induced Antinociception in Acute Thermal and Nerve Injury Mouse Pain Models: Role of Sphingosine-1-Phosphate Receptor Adaptation
Laura J. Sim-Selley et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn
Suzanne Doolen et al.
PAIN (2018)
Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation
Shaness A. Grenald et al.
PAIN (2017)
Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation
Veit Rothhammer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Balancing the immune response in the brain: IL-10 and its regulation
Diogo Lobo-Silva et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Antinociceptive effects of FTY720 during trauma-induced neuropathic pain are mediated by spinal S1P receptors
Dong Dong Zhang et al.
BIOLOGICAL CHEMISTRY (2015)
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Nanna B. Finnerup et al.
LANCET NEUROLOGY (2015)
The therapeutic potential of interleukin-10 in neuroimmune diseases
A. J. Kwilasz et al.
NEUROPHARMACOLOGY (2015)
Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
Simona F. Spampinato et al.
PLOS ONE (2015)
Second generation S1P pathway modulators: Research strategies and clinical developments
Marc Bigaud et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice
J. Dong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
TGFβ produced by IL-10 redirected astrocytes attenuates microglial activation
Diana M. Norden et al.
GLIA (2014)
The Development and Maintenance of Paclitaxel-induced Neuropathic Pain Require Activation of the Sphingosine 1-Phosphate Receptor Subtype 1
Kali Janes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Farber disease: understanding a fatal childhood disorder and dissecting ceramide biology
Mark S. Sands
EMBO MOLECULAR MEDICINE (2013)
Endogenous Interleukin-1β in Neuropathic Rats Enhances Glutamate Release from the Primary Afferents in the Spinal Dorsal Horn through Coupling with Presynaptic N-Methyl-D-aspartic Acid Receptors
Xisheng Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain
Daniela Salvemini et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator
Shifeng Pan et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy
Jens Ingwersen et al.
CLINICAL IMMUNOLOGY (2012)
Amelioration of Collagen-Induced Arthritis by a Novel S1P1 Antagonist with Immunomodulatory Activities
Yasuyuki Fujii et al.
JOURNAL OF IMMUNOLOGY (2012)
An Oral Sphingosine 1-Phosphate Receptor 1 (S1P1) Antagonist Prodrug with Efficacy in Vivo: Discovery, Synthesis, and Evaluation
Daniela Angst et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
Christina E. Zielinski et al.
NATURE (2012)
Mouse Estrous Cycle Identification Tool and Images
Shannon L. Byers et al.
PLOS ONE (2012)
The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice
Gema Tarrason et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
A population-based survey of chronic pain and its treatment with prescription drugs
Robin L. Toblin et al.
PAIN (2011)
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
Ji Woong Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
Jerold Chun et al.
CLINICAL NEUROPHARMACOLOGY (2010)
2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1 Receptor Agonists
Martin H. Bolli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Volker Brinkmann et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Role of interleukin-1β during pain and inflammation
Ke Ren et al.
BRAIN RESEARCH REVIEWS (2009)
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
Volker Brinkmann
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Sphingosine 1-Phosphate Modulates Spinal Nociceptive Processing
Ovidiu Coste et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Antinociceptive activity of the S1P-receptor agonist FTY720
Ovidiu Coste et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
"Inside-Out" Signaling of Sphingosine-1-Phosphate: Therapeutic Targets
K. Takabe et al.
PHARMACOLOGICAL REVIEWS (2008)
An efficient total synthesis of a sphingosine-1-phosphate receptor agonist KRP-203
Masao Chino et al.
TETRAHEDRON (2008)
The alliance of sphingosine-1-phosphate and its receptors in immunity
Juan Rivera et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The neuropathic pain triad: Neurons, immune cells and glia
Joachim Scholz et al.
NATURE NEUROSCIENCE (2007)
Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain
Wei Guo et al.
JOURNAL OF NEUROSCIENCE (2007)
Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo
M. Germana Sanna et al.
NATURE CHEMICAL BIOLOGY (2006)
S1P1-selective in vivo-active agonists from high-throughput screening:: Off-the-shelf chemical probes of receptor interactions, signaling, and fate
EJ Jo et al.
CHEMISTRY & BIOLOGY (2005)
Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate
MG Sanna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I
JL Dawkins et al.
NATURE GENETICS (2001)
Spared nerve injury: an animal model of persistent peripheral neuropathic pain
I Decosterd et al.
PAIN (2000)
分享论文
